Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): As of December 31, 2023, the company's cumulative cash dividend paid has exceeded RMB 700 million.

Gelonghui Finance · Jul 3 05:30

Zhejiang Wolwo Bio-pharmaceutical (300357.SZ) stated on the investor interactive platform that cash dividends are an important way to reward shareholders, and since its listing, the company has distributed profits in cash each year that are more than 30% of the net income attributable to shareholders of the listed company in that year, returning to all shareholders. As of December 31, 2023, the total amount of cash dividends implemented by the company has exceeded 700 million yuan, which is equivalent to about three times the amount of funds raised in the initial public offering.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

我武生物(300357.SZ)：截至2023年12月31日，公司累计实施的现金分红总额已超7亿元

Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): As of December 31, 2023, the company's cumulative cash dividend paid has exceeded RMB 700 million.

Risk Disclaimer

Statement